Advertisement
Table 1 Baseline characteristics of patients with HCAP, HAP, or VAP
| Baseline characteristic | HCAP | HAP | VAP | p value |
|---|---|---|---|---|
| (n = 199) | (n = 379) | (n = 606) | ||
| Age, y, mean (SD) | 69.5 (13.4) | 63.3 (15.8) | 55.8 (19.8) | < 0.001 |
| Male, n (%) | 117 (58.8) | 247 (65.2) | 411 (67.8) | 0.067 |
| APACHE II, mean (SD) | 18.7 (6.4) | 16.1 (6.3) | 17.8 (5.7) | < 0.001 |
| Race, n (%) | < 0.001 | |||
| White | 151 (75.9) | 217 (57.3) | 429 (70.8) | |
| Black | 25 (12.6) | 28 (7.4) | 72 (11.9) | |
| Asian | 18 (9.1) | 97 (25.6) | 56 (9.2) | |
| Other | 5 (2.5) | 37 (9.8) | 49 (8.1) | |
| Region, n (%) | < 0.001 | |||
| United States | 174 (87.4) | 163 (43.0) | 376 (62.1) | |
| Europe | 6 (3.0) | 51 (13.5) | 84 (13.9) | |
| Latin America | 2 (1.0) | 43 (11.4) | 78 (12.9) | |
| Asia | 14 (7.0) | 93 (24.5) | 49 (8.1) | |
| Other | 3 (1.5) | 29 (7.7) | 19 (3.1) | |
| Comorbidities, n (%) | ||||
| Cardiac | 153 (76.9) | 198 (52.2) | 359 (59.2) | < 0.001 |
| Pulmonary | 164 (82.4) | 186 (49.1) | 387 (63.9) | < 0.001 |
| Renal/Urinary | 110 (55.3) | 127 (33.5) | 194 (32.0) | < 0.001 |
| Diabetes | 98 (49.3) | 128 (33.8) | 198 (32.7) | < 0.001 |
| Vascular | 74 (37.2) | 109 (28.8) | 187 (30.9) | 0.111 |
| Neoplastic | 23 (11.6) | 68 (17.9) | 42 (6.9) | < 0.001 |
| Hepatobiliary | 17 (8.5) | 42 (11.1) | 91 (15.0) | 0.031 |
